Germany’s Bayer has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its glyphosate-based weed killers to allow more time for talks on a settlement.
Recent Posts
Most Popular
US regulators reconsider capital hike for big banks
THE Federal Reserve and two other US regulators are moving towards a new plan that would significantly reduce a nearly 20 per cent mandated...
Deutsche Bank’s risk transfer enables more green mortgages
DEUTSCHE Bank has entered a capital-relief deal with the European Investment Bank (EIB) that allows the German lender to grant discounts on more than...